Skip to Content
Stanford Medicine Diehn Lab

Diehn Lab
Stanford Medicine

Explore Stanford Medicine

  • Health Care
    • Find a doctor

    • Adult-care doctor
    • Pediatrician or pediatric specialist
    • Obstetrician
    • Clinics & Services

    • Adult care
    • Pediatric care
    • Obstetrics
    • Clinical trials
    • Locations

    • Stanford Health Care
    • Stanford Children's Health
    • Emergency Department
    • Dial 911 in the event of a medical emergency

    Explore Health Care

    Learn how we are healing patients through science & compassion

    Back
  • Research
    • Basic science departments
    • Clinical science departments
    • Institutes
    • Research centers
    • See full directory
    • Research Resources

    • Research administration
    • Academic profiles
    • Clinical trials
    • Funding opportunities
    • See all
    • Professional Training

    • Postdoctoral scholars
    • Clinical research fellows

    Research News

    Neuroscientist Michelle Monje awarded MacArthur 'genius grant'

    Neuroscientist Michelle Monje awarded MacArthur 'genius grant'

    Explore Research

    Learn how we are fueling innovation

    Back
  • Education
    • MD program
    • PA Programs
    • PhD programs
    • Masters programs
    • Continuing Medical Education
    • Postdoctoral scholars
    • Residencies & fellowships
    • High School & Undergraduate Programs
    • See all
    • Education Resources

    • Academic profiles
    • School Administration
    • Basic science departments
    • Clinical science departments
    • Alumni services
    • Faculty resources
    • Diversity programs
    • Lane Library
    • Student resources

    Education News

    Alice L. Walton School of Medicine and Stanford Medicine host AI conference on community health

    Alice L. Walton School of Medicine and Stanford Medicine host AI conference on community health

    Explore Education

    Learn how we empower tomorrow's leaders

    Back
  • Give

    Support Stanford Medicine

    • Support teaching, research, and patient care.

    • Ways to give
    • Why giving matters
    • Make a gift online

    Support Children's Health

    • Support Lucile Packard Children's Hospital Stanford and child and maternal health

    • Ways to give
    • How your gift helps
    • Make an online gift
    Back
  • About
    • About us
    • News
    • Contacts
    • Maps & directions
    • Leadership
    • Vision
    • Diversity
    • Global health
    • Community engagement
    • Events
    • How you can help

    Stanford School of Medicine

    Stanford Health Care

    Stanford Children's Health

    Back
  • Site Search

News

  • Molecular prognostic index may predict survival in early-stage NSCLC
    September 1, 2015 – Molecular prognostic index may predict survival in early

    Molecular prognostic index may predict survival in early-stage NSCLC

    A nine-gene molecular prognostic index provided accurate risk stratification and may be used to inform adjuvant therapy for patients with early-stage non–small cell lung cancer, according to the results of a retrospective analysis.“We set out to develop a predictor that could identify which patients with early-stage NSCLC are at highest risk for dying of the disease,” Maximilian

  • Nine-gene MPI can provide accurate survival stratification in patients with NSCLC
    August 28, 2015 – EurekAlert!

    Nine-gene MPI can provide accurate survival stratification in patients with NSCLC

    A nine-gene molecular prognostic index for patients with early-stage non-small cell lung cancer was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease, according to a study published Aug. 18 in the JNCI: Journal of the National Cancer Institute.

  • How Blood Tests Are Changing Medicine
    June 15, 2015 – Time

    How Blood Tests Are Changing Medicine

    New advances have scientists banking on the idea that the most revealing medical test might be a single drop of your own blood

  • November 20, 2014 – A Genomic Strategy for Residual Disease Monitoring in Non

    A Genomic Strategy for Residual Disease Monitoring in Non-Small Cell Lung Cancer

    What is the most important thing that stakeholders should know about your research?

  • Experts Convene at CSHL to Scrutinize, Assess Low-Dose CT Screening for Lung Cancer
    October 20, 2014 – LongIsland.com

    Experts Convene at CSHL to Scrutinize, Assess Low-Dose CT Screening for Lung Cancer

    At the first annual Lung Cancer Early Detection and Prevention Workshop held at Cold Spring Harbor Laboratory (CSHL) in late September, nearly two dozen physicians, research scientists and hospital administrators took a close scientific view of rapid advances made in recent years to identify lung ca

  • New test spots traces of early lung cancer
    May 16, 2014 – ABC7 San Francisco

    New test spots traces of early lung cancer

    The blood test can spot the traces of early lung cancer, long before it might be caught by an imaging test.

  • Simple blood test may detect solid cancer tumors
    April 9, 2014 – SFGate

    Simple blood test may detect solid cancer tumors

    Using tumor samples from patients with non-small-cell lung cancer, the most common form of the disease, the scientists developed a test that accurately identified the earliest stage of the disease in half the people in the study and in all patients with more advanced lung cancer.

  • Simple Blood Test Could Detect Cancer Early
    April 7, 2014 – VOA

    Simple Blood Test Could Detect Cancer Early

    Early detection screening may be 5 to 10 years off, but the test may also be used for monitoring treatment much sooner

  • Simple blood test could detect cancers
    April 7, 2014 – Fox News

    Simple blood test could detect cancers

    A new, highly sensitive blood test may help detect cancer tumors, Medical News Today reported.

  • Cancer blood test edging closer Labmate Online
    April 7, 2014 – Cancer blood test edging closer Labmate Online

    Cancer blood test edging closer Labmate Online

    New research suggests that soon doctors will be able to diagnose and track cancer through a simple blood test. Click to read more...


Newer Stories

TV and Radio

  • Dr. Diehn on Next Steps With Liquid Biopsies in Lung Cancer
    January 8, 2019 – OncLive

    Dr. Diehn on Next Steps With Liquid Biopsies in Lung Cancer

    Maximilian Diehn, MD, PhD, an assistant professor in the Department of Radiation Oncology, Stanford Medicine, discusses some of the next steps researchers are taking with liquid biopsies in the field of lung cancer.

  • ctDNA Predicts Outcomes in Lung Cancer Patients Receiving Radiation Therapy
    November 14, 2017 – Cancer Network

    ctDNA Predicts Outcomes in Lung Cancer Patients Receiving Radiation Therapy

    This peer-to-peer exchange highlights results of a study that tested whether analyzing circulating tumor DNA (ctDNA) during treatment with chemoradiotherapy could predict outcomes in patients with localized lung cancer.

  • Cancer Test Featured on 'KUWTK' Being Investigated: Details
    February 9, 2016 – Us Weekly

    Cancer Test Featured on 'KUWTK' Being Investigated: Details

    The Pathway Genomics–created cancer test that was featured on 'Keeping Up With the Kardashians' is being investigated by CBS News for possibly promising patients more than current medical science can deliver — details

  • Blood test giving false sense of security about cancer risk?
    February 9, 2016 – Blood test giving false sense of security about cancer risk?

    Blood test giving false sense of security about cancer risk?

    Pathway Genomics claims its liquid biopsy can detect cancer before patient shows symptoms - but expert says that promise is "years away"

  • Spotting Cancer DNA in the Blood
    April 15, 2014 – Vimeo

    Spotting Cancer DNA in the Blood

    Stanford researchers are able to find and analyze DNA that cancer cells shed into the bloodstream, offering them a way to monitor the progress of anticancer therapy,…


Stanford Medicine News

  • January 28, 2019 – News Center

    Stanford scientists among those funded by Stand Up To Cancer

    Maximilian Diehn, Sanjiv “Sam” Gambhir, Ash Alizadeh and Young-Jun Jeon will work on “dream teams” aiming to improve detection of cancer.

  • May 3, 2018 – News Center

    Stanford scientists among those funded by Stand Up To Cancer

    Maximilian Diehn, Sanjiv “Sam” Gambhir, Ash Alizadeh and Young-Jun Jeon will work on “dream teams” aiming to improve detection of cancer.

  • November 15, 2017 – News Center

    Stanford scientists among those funded by Stand Up To Cancer

    Maximilian Diehn, Sanjiv “Sam” Gambhir, Ash Alizadeh and Young-Jun Jeon will work on “dream teams” aiming to improve detection of cancer.

  • September 28, 2017 – Scope

    Predicting lung cancer recurrence by analyzing circulating tumor DNA - Scope

    I've mentioned before how circulating tumor DNA, or ctDNA, is likely to be a valuable tool for predicting disease recurrence in patients with lymphoma. Now …

  • March 28, 2016 – News Center

    Improved 'liquid biopsy' technique enhances detection of tumor DNA in blood

    People with cancer have tumor DNA in their blood. A new way to quiet background “noise” in the blood sample allows researchers to sequence minute quantities of these molecules to improve diagnosis and treatment.


World News

  • February 12, 2015 – mirror

    Scientists offer hope to cancer patients forced to endure painful tests

    Researchers believe painful biopsies could be replaced with a simple blood tests, ending the painful tests for many

  • February 12, 2015

    Krebsdiagnose aus dem Blut

    Von Ilse Zündorf, Freiburg / Bislang werden Tumore über eine Biopsie analysiert. Doch auch das Blut hält Informationen in Form von freier Tumor-DNA oder einzelnen Tumor-Zellen bereit. Wie weit die Forschung auf dem Gebiet der sogenannten Tumor Liquid Biopsy bereits ist, stellten Experten kürzlich auf einem Symposium in Freiburg vor.

  • August 4, 2014 – PLIVAzdravlje

    Krvni test za rak

    Američki znanstvenici sa Stanford University su razvili visoko osjetljivi test kojim je moguće otkriti prisutnost raka na temelju uzorka krvi.

  • August 4, 2014 – Αιματολογική εξέταση εντοπίζει τους στερεούς καρκινικους όγκους

    Αιματολογική εξέταση εντοπίζει τους στερεούς καρκινικους όγκους

    Νέα Yόρκη: Μια νέα αιματολογική εξέταση ανέπτυξαν αμερικανοί ερευνητές που υπόσχεται έγκαιρη διάγνωση των στερεών καρκινικών όγκων, σύμφωνα με στοιχεία που δημοσιεύθηκαν στο επιστημονικό...

  • August 4, 2014 – Real.gr

    Τεστ DNA «θα ανιχνεύει γρήγορα τον καρκίνο»

    Τεστ DNA «θα ανιχνεύει γρήγορα τον καρκίνο» - Νέα τεχνική από επιστήμονες του Πανεπιστημίου Στάνφορντ8/4/2014 - αρχείο real news, time - Real.gr

On This Page

On This Page

Diehn Lab
  • In the News
  • People
  • Projects
  • Publications
  • Contact Us
  • Support Our Research
  • Opportunities

Affiliated Sites

  • Radiation Oncology Home
  • Stem Cell Institute
  • Cancer Institute

Diehn Lab

Stanford Medicine

News

Careers

Contact

Health Care

Stanford Health Care

Stanford Children's Health

Stanford School of Medicine

About

Contact

Maps & Directions

Careers

Basic Science Departments

Clinical Science Departments

Academic Programs

Vision

Find People
Visit Stanford
Search Clinical Trials
Give a Gift
©2025 Stanford University
  • Privacy Policy
  • Terms of Use
  • Accessibility
  • Non-Discrimination
  • See us on Facebook
  • See us on X (Twitter)

Non-Discrimination

Stanford complies with all applicable civil rights laws and does not engage in illegal preferences or discrimination.
Stanford's Non-Discrimination Policy

  • Stanford University
  • Stanford School of Medicine
  • Stanford Health Care
  • Stanford Children's Health
  • Stanford Health Care Tri-Valley
  • Stanford Medicine Partners